Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1

Fig. 1

LncRNA EPB41L4A-AS2 is downregulated in hepatocellular carcinoma. a EPB41L4A-AS2 is downregulated in hepatocellular carcinoma cell line SMMC-7721, QGY-7703 and Huh7 compared with hepatocyte cell line QSG-7701; b-c EPB41L4A-AS2 is downregulated in mice hepatocarcinoma model induced by AFB1 (n = 6); d EPB41L4A-AS2 is downregulated in tissues of hepatocellular carcinoma (n = 10); e The expression of EPB41L4A-AS2 in portal vein tumor thrombus is lower than that of primary tumor tissues

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us